A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma

Abstract

We developed a targeted NGS approach to identify tumor-specific alterations in ctDNA of neuroblastoma patients. Our results show the reliability of our approach to generate genomic information which can be integrated with clinical and pathological data at diagnosis.